KŘEN, Leoš, Ivo VALKOVSKÝ, Jan DOLEŽEL, Ivo ČAPÁK, Dalibor PACÍK, Alexandr POPRACH, Radek LAKOMÝ, Martina RÉDOVÁ, Pavel FABIAN, Zdenka KŘENOVÁ and Ondřej SLABÝ. HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma. Diagnostic Pathology. LONDON: BIOMED CENTRAL LTD, 2012, vol. 7, No 1, p. 58-64. ISSN 1746-1596. Available from: https://dx.doi.org/10.1186/1746-1596-7-58.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma
Authors KŘEN, Leoš (203 Czech Republic, guarantor, belonging to the institution), Ivo VALKOVSKÝ (203 Czech Republic), Jan DOLEŽEL (203 Czech Republic), Ivo ČAPÁK (203 Czech Republic), Dalibor PACÍK (203 Czech Republic, belonging to the institution), Alexandr POPRACH (203 Czech Republic), Radek LAKOMÝ (203 Czech Republic), Martina RÉDOVÁ (203 Czech Republic, belonging to the institution), Pavel FABIAN (203 Czech Republic), Zdenka KŘENOVÁ (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution).
Edition Diagnostic Pathology, LONDON, BIOMED CENTRAL LTD, 2012, 1746-1596.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.850
RIV identification code RIV/00216224:14110/12:00060120
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/1746-1596-7-58
UT WoS 000306977900001
Keywords in English renal cell carcinoma; radiotherapy; chemotherapy; HLA-G; HLA-E
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 22/4/2013 18:23.
Abstract
Background: Renal cell carcinoma (RCC) is characterized by its resistance to radiotherapy and/or chemotherapy. On the other hand, it is an immunogenic tumor - it is able to stimulate antitumor responses. A prognostic significance of HLA-G expression by neoplastic cells in RCC is not well characterized; significance HLA-E expression in RCC is not characterized at all. Methods: In our study, we evaluated the expression of HLA-G and HLA-E specific mRNA transcripts produced by neoplastic cells in 38 cases of RCC and in 10 samples of normal kidney parenchyma. The results were statistically correlated with various clinico-pathological parameters. Results: We confirmed that HLA-G is downregulated in normal kidney tissue; if it is up-regulated in RCC, then it is connected to worse prognosis. On the other hand, HLA-E mRNA transcripts were present in both normal kidney tissue and RCC and their increasing concentrations counterintuitively carried better prognosis, more favorable pT stage and lower nuclear Fuhrmann's grade. Conclusion: Considering the fact that there is known aberrant activation of HLA-G and HLA-E expression by interferons, identification of HLA-G and HLA-E status could contribute to better selection of RCC patients who could possibly benefit from more tailored neoadjuvant biological/immunological therapy. Thus, these molecules could represent useful prognostic biomarkers in RCC, and the expression of both these molecules in RCC deserves further study. The virtual: Slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/7383071387016614
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 8/7/2024 16:26